BRD1_HUMAN - dbPTM
BRD1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BRD1_HUMAN
UniProt AC O95696
Protein Name Bromodomain-containing protein 1
Gene Name BRD1
Organism Homo sapiens (Human).
Sequence Length 1058
Subcellular Localization Nucleus .
Protein Description Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity..
Protein Sequence MRRKGRCHRGSAARHPSSPCSVKHSPTRETLTYAQAQRMVEIEIEGRLHRISIFDPLEIILEDDLTAQEMSECNSNKENSERPPVCLRTKRHKNNRVKKKNEALPSAHGTPASASALPEPKVRIVEYSPPSAPRRPPVYYKFIEKSAEELDNEVEYDMDEEDYAWLEIVNEKRKGDCVPAVSQSMFEFLMDRFEKESHCENQKQGEQQSLIDEDAVCCICMDGECQNSNVILFCDMCNLAVHQECYGVPYIPEGQWLCRHCLQSRARPADCVLCPNKGGAFKKTDDDRWGHVVCALWIPEVGFANTVFIEPIDGVRNIPPARWKLTCYLCKQKGVGACIQCHKANCYTAFHVTCAQKAGLYMKMEPVKELTGGGTTFSVRKTAYCDVHTPPGCTRRPLNIYGDVEMKNGVCRKESSVKTVRSTSKVRKKAKKAKKALAEPCAVLPTVCAPYIPPQRLNRIANQVAIQRKKQFVERAHSYWLLKRLSRNGAPLLRRLQSSLQSQRSSQQRENDEEMKAAKEKLKYWQRLRHDLERARLLIELLRKREKLKREQVKVEQVAMELRLTPLTVLLRSVLDQLQDKDPARIFAQPVSLKEVPDYLDHIKHPMDFATMRKRLEAQGYKNLHEFEEDFDLIIDNCMKYNARDTVFYRAAVRLRDQGGVVLRQARREVDSIGLEEASGMHLPERPAAAPRRPFSWEDVDRLLDPANRAHLGLEEQLRELLDMLDLTCAMKSSGSRSKRAKLLKKEIALLRNKLSQQHSQPLPTGPGLEGFEEDGAALGPEAGEEVLPRLETLLQPRKRSRSTCGDSEVEEESPGKRLDAGLTNGFGGARSEQEPGGGLGRKATPRRRCASESSISSSNSPLCDSSFNAPKCGRGKPALVRRHTLEDRSELISCIENGNYAKAARIAAEVGQSSMWISTDAAASVLEPLKVVWAKCSGYPSYPALIIDPKMPRVPGHHNGVTIPAPPLDVLKIGEHMQTKSDEKLFLVLFFDNKRSWQWLPKSKMVPLGIDETIDKLKMMEGRNSSIRKAVRIAFDRAMNHLSRVHGEPTSDLSDID
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
11PhosphorylationKGRCHRGSAARHPSS
CCCCCCCCCCCCCCC
20.7923312004
17PhosphorylationGSAARHPSSPCSVKH
CCCCCCCCCCCCCCC
40.5622167270
18PhosphorylationSAARHPSSPCSVKHS
CCCCCCCCCCCCCCC
34.0823401153
21PhosphorylationRHPSSPCSVKHSPTR
CCCCCCCCCCCCCCH
37.2722167270
23AcetylationPSSPCSVKHSPTRET
CCCCCCCCCCCCHHH
23.2821466224
25PhosphorylationSPCSVKHSPTRETLT
CCCCCCCCCCHHHEE
23.4223401153
27PhosphorylationCSVKHSPTRETLTYA
CCCCCCCCHHHEEHH
44.1222167270
30PhosphorylationKHSPTRETLTYAQAQ
CCCCCHHHEEHHHHH
22.5524117733
32PhosphorylationSPTRETLTYAQAQRM
CCCHHHEEHHHHHHH
25.0030576142
33PhosphorylationPTRETLTYAQAQRMV
CCHHHEEHHHHHHHE
10.3830576142
33 (in isoform 2)Phosphorylation-10.3827642862
66PhosphorylationIILEDDLTAQEMSEC
HHHCCCCCHHHHHHH
33.0328348404
71PhosphorylationDLTAQEMSECNSNKE
CCCHHHHHHHHCCCC
37.9426074081
75PhosphorylationQEMSECNSNKENSER
HHHHHHHCCCCCCCC
62.0225849741
100AcetylationKNNRVKKKNEALPSA
CCCCCCCCCCCCCCC
55.0626051181
106PhosphorylationKKNEALPSAHGTPAS
CCCCCCCCCCCCCCC
33.4729496963
110PhosphorylationALPSAHGTPASASAL
CCCCCCCCCCCCCCC
13.0529496963
113PhosphorylationSAHGTPASASALPEP
CCCCCCCCCCCCCCC
24.7827732954
115PhosphorylationHGTPASASALPEPKV
CCCCCCCCCCCCCCE
28.0427732954
127PhosphorylationPKVRIVEYSPPSAPR
CCEEEEEECCCCCCC
18.6428102081
128PhosphorylationKVRIVEYSPPSAPRR
CEEEEEECCCCCCCC
19.4829255136
131PhosphorylationIVEYSPPSAPRRPPV
EEEECCCCCCCCCCC
55.0525159151
277AcetylationDCVLCPNKGGAFKKT
CEEECCCCCCCCCCC
43.8126822725
324AcetylationNIPPARWKLTCYLCK
CCCHHHHEEEEHHHC
28.5023749302
328PhosphorylationARWKLTCYLCKQKGV
HHHEEEEHHHCCCCC
15.20-
331AcetylationKLTCYLCKQKGVGAC
EEEEHHHCCCCCCEE
53.0723749302
333AcetylationTCYLCKQKGVGACIQ
EEHHHCCCCCCEEEE
40.8526051181
343AcetylationGACIQCHKANCYTAF
CEEEEECCCCCEEEE
49.2525953088
357AcetylationFHVTCAQKAGLYMKM
EEHHHHHHCCEEEEE
26.3725953088
361PhosphorylationCAQKAGLYMKMEPVK
HHHHCCEEEEEEEEE
8.1829759185
363AcetylationQKAGLYMKMEPVKEL
HHCCEEEEEEEEEEC
26.9325953088
368UbiquitinationYMKMEPVKELTGGGT
EEEEEEEEECCCCCC
58.6921890473
368AcetylationYMKMEPVKELTGGGT
EEEEEEEEECCCCCC
58.6919608861
368UbiquitinationYMKMEPVKELTGGGT
EEEEEEEEECCCCCC
58.6921890473
368 (in isoform 2)Ubiquitination-58.69-
407AcetylationIYGDVEMKNGVCRKE
EECCEEEECCEECCC
36.7223749302
413AcetylationMKNGVCRKESSVKTV
EECCEECCCCCCCHH
57.7423749302
415PhosphorylationNGVCRKESSVKTVRS
CCEECCCCCCCHHHC
43.39-
416PhosphorylationGVCRKESSVKTVRST
CEECCCCCCCHHHCH
28.82-
418AcetylationCRKESSVKTVRSTSK
ECCCCCCCHHHCHHH
43.1623749302
422O-linked_GlycosylationSSVKTVRSTSKVRKK
CCCCHHHCHHHHHHH
32.4730379171
422PhosphorylationSSVKTVRSTSKVRKK
CCCCHHHCHHHHHHH
32.47-
446PhosphorylationEPCAVLPTVCAPYIP
CCCCCCCCCCCCCCC
24.85-
451PhosphorylationLPTVCAPYIPPQRLN
CCCCCCCCCCHHHHH
13.92-
486PhosphorylationYWLLKRLSRNGAPLL
HHHHHHHHHCCHHHH
27.9426029660
498PhosphorylationPLLRRLQSSLQSQRS
HHHHHHHHHHHHHHH
37.2925884760
499PhosphorylationLLRRLQSSLQSQRSS
HHHHHHHHHHHHHHH
19.9130266825
502PhosphorylationRLQSSLQSQRSSQQR
HHHHHHHHHHHHHHH
32.6230266825
516AcetylationRENDEEMKAAKEKLK
HHCHHHHHHHHHHHH
48.7719608861
519AcetylationDEEMKAAKEKLKYWQ
HHHHHHHHHHHHHHH
61.3119608861
521AcetylationEMKAAKEKLKYWQRL
HHHHHHHHHHHHHHH
49.9626051181
523AcetylationKAAKEKLKYWQRLRH
HHHHHHHHHHHHHHH
56.3519608861
523UbiquitinationKAAKEKLKYWQRLRH
HHHHHHHHHHHHHHH
56.35-
523 (in isoform 2)Ubiquitination-56.35-
554AcetylationKLKREQVKVEQVAME
HHHHHHCCHHHHHHH
39.4823749302
554SumoylationKLKREQVKVEQVAME
HHHHHHCCHHHHHHH
39.4828112733
554UbiquitinationKLKREQVKVEQVAME
HHHHHHCCHHHHHHH
39.48-
581AcetylationVLDQLQDKDPARIFA
HHHHHCCCCHHHHHC
53.2926051181
594AcetylationFAQPVSLKEVPDYLD
HCCCCCHHHCCHHHH
49.5126051181
594SumoylationFAQPVSLKEVPDYLD
HCCCCCHHHCCHHHH
49.5128112733
594UbiquitinationFAQPVSLKEVPDYLD
HCCCCCHHHCCHHHH
49.51-
604AcetylationPDYLDHIKHPMDFAT
CHHHHHCCCCCCHHH
37.9325953088
614AcetylationMDFATMRKRLEAQGY
CCHHHHHHHHHHCCC
50.9819813111
622AcetylationRLEAQGYKNLHEFEE
HHHHCCCCCHHHHHH
60.9119813121
641PhosphorylationIIDNCMKYNARDTVF
HHHCHHHCCCCCCEE
6.2826074081
732AcetylationLDLTCAMKSSGSRSK
HHHHHHHHCCCCHHH
23.9725953088
754AcetylationEIALLRNKLSQQHSQ
HHHHHHHHHHHHCCC
42.9825953088
754UbiquitinationEIALLRNKLSQQHSQ
HHHHHHHHHHHHCCC
42.98-
756PhosphorylationALLRNKLSQQHSQPL
HHHHHHHHHHCCCCC
29.4226714015
756 (in isoform 2)Phosphorylation-29.4222210691
760PhosphorylationNKLSQQHSQPLPTGP
HHHHHHCCCCCCCCC
29.2026714015
760 (in isoform 2)Phosphorylation-29.2022210691
790 (in isoform 2)Phosphorylation-40.7829507054
793PhosphorylationEVLPRLETLLQPRKR
HHHHHHHHHHCCCCC
37.0426074081
801PhosphorylationLLQPRKRSRSTCGDS
HHCCCCCCCCCCCCC
33.3523401153
803PhosphorylationQPRKRSRSTCGDSEV
CCCCCCCCCCCCCCC
29.3323401153
804PhosphorylationPRKRSRSTCGDSEVE
CCCCCCCCCCCCCCC
21.2823927012
808PhosphorylationSRSTCGDSEVEEESP
CCCCCCCCCCCCCCC
28.9120164059
814PhosphorylationDSEVEEESPGKRLDA
CCCCCCCCCCCCCCC
42.0823927012
817AcetylationVEEESPGKRLDAGLT
CCCCCCCCCCCCCCC
53.8525953088
832PhosphorylationNGFGGARSEQEPGGG
CCCCCCCCCCCCCCC
43.00-
837 (in isoform 2)Phosphorylation-41.8922210691
839 (in isoform 2)Phosphorylation-30.7622210691
845PhosphorylationGGLGRKATPRRRCAS
CCCCCCCCCCCCCCC
21.9927282143
852PhosphorylationTPRRRCASESSISSS
CCCCCCCCCCCCCCC
41.4527273156
854PhosphorylationRRRCASESSISSSNS
CCCCCCCCCCCCCCC
30.4027273156
855PhosphorylationRRCASESSISSSNSP
CCCCCCCCCCCCCCC
23.5727273156
857PhosphorylationCASESSISSSNSPLC
CCCCCCCCCCCCCCC
29.6628102081
858PhosphorylationASESSISSSNSPLCD
CCCCCCCCCCCCCCC
31.6928102081
859PhosphorylationSESSISSSNSPLCDS
CCCCCCCCCCCCCCC
34.2427273156
861PhosphorylationSSISSSNSPLCDSSF
CCCCCCCCCCCCCCC
22.6123403867
866PhosphorylationSNSPLCDSSFNAPKC
CCCCCCCCCCCCCCC
35.5123403867
867PhosphorylationNSPLCDSSFNAPKCG
CCCCCCCCCCCCCCC
14.8523403867
875 (in isoform 2)Phosphorylation-60.4722210691
877AcetylationAPKCGRGKPALVRRH
CCCCCCCCCCHHCCC
26.2523749302
881 (in isoform 2)Phosphorylation-5.7020860994
882 (in isoform 2)Phosphorylation-26.0525159151
885PhosphorylationPALVRRHTLEDRSEL
CCHHCCCCCCCHHHH
29.9927273156
888 (in isoform 2)Phosphorylation-63.6230177828
890PhosphorylationRHTLEDRSELISCIE
CCCCCCHHHHHHHHH
49.4229214152
890 (in isoform 2)Phosphorylation-49.4230177828
892 (in isoform 2)Phosphorylation-3.5430177828
894PhosphorylationEDRSELISCIENGNY
CCHHHHHHHHHCCCH
22.9723882029
900 (in isoform 2)Phosphorylation-45.2128111955
902 (in isoform 2)Phosphorylation-10.0630266825
903AcetylationIENGNYAKAARIAAE
HHCCCHHHHHHHHHH
32.0219608861
905 (in isoform 2)Phosphorylation-11.6030266825
906 (in isoform 2)Phosphorylation-24.7630266825
911 (in isoform 2)Phosphorylation-7.8827987026
915PhosphorylationAAEVGQSSMWISTDA
HHHHCCCCEEECCHH
15.3923532336
920PhosphorylationQSSMWISTDAAASVL
CCCEEECCHHHHHHH
22.1123532336
932 (in isoform 2)Phosphorylation-5.9825159151
936AcetylationPLKVVWAKCSGYPSY
CHHHHEEECCCCCCC
17.1425953088
951AcetylationPALIIDPKMPRVPGH
CEEEECCCCCCCCCC
58.7626051181
981AcetylationIGEHMQTKSDEKLFL
ECCCCCCCCCCCEEE
38.7323749302
995AcetylationLVLFFDNKRSWQWLP
EEEEECCCCCEEECC
50.0511925801
1003AcetylationRSWQWLPKSKMVPLG
CCEEECCHHCCEECC
61.6126051181
1005AcetylationWQWLPKSKMVPLGID
EEECCHHCCEECCCC
50.4725953088
1016 (in isoform 2)Phosphorylation-58.62-
1017UbiquitinationGIDETIDKLKMMEGR
CCCHHHHHHHHHCCC
46.27-
1026PhosphorylationKMMEGRNSSIRKAVR
HHHCCCCHHHHHHHH
26.2821406692
1027PhosphorylationMMEGRNSSIRKAVRI
HHCCCCHHHHHHHHH
29.9321406692
1051PhosphorylationSRVHGEPTSDLSDID
HHHCCCCCCCCCCCC
30.4822167270
1052PhosphorylationRVHGEPTSDLSDID-
HHCCCCCCCCCCCC-
47.4722167270
1055PhosphorylationGEPTSDLSDID----
CCCCCCCCCCC----
37.1922167270
1126 (in isoform 2)Acetylation--

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of BRD1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BRD1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BRD1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
VIME_HUMANVIMphysical
16169070
CE126_HUMANKIAA1377physical
16169070
CREST_HUMANSS18L1physical
20211142
H33_HUMANH3F3Aphysical
21880731
H32_HUMANHIST2H3Cphysical
21720545
ZC3HF_HUMANZC3H15physical
27142060
DRG1_HUMANDRG1physical
27142060
C1QBP_HUMANC1QBPphysical
27142060
KAT7_HUMANKAT7physical
27142060
KMT5B_HUMANSUV420H1physical
27142060
EAF6_HUMANMEAF6physical
27142060
1433E_HUMANYWHAEphysical
27142060
PB1_HUMANPBRM1physical
27142060
ING4_HUMANING4physical
27142060
ING5_HUMANING5physical
27142060
NPM_HUMANNPM1physical
27142060
1433Z_HUMANYWHAZphysical
27142060
IMA5_HUMANKPNA1physical
27142060
IMA1_HUMANKPNA2physical
27142060
CHD3_HUMANCHD3physical
27142060
CHD4_HUMANCHD4physical
27142060
CHD5_HUMANCHD5physical
27142060
1433B_HUMANYWHABphysical
27142060
NP1L4_HUMANNAP1L4physical
27142060
CLH1_HUMANCLTCphysical
27142060
DNMT1_HUMANDNMT1physical
27142060
LYAR_HUMANLYARphysical
27142060
RT14_HUMANMRPS14physical
27142060
EIF3I_HUMANEIF3Iphysical
27142060
PHB2_HUMANPHB2physical
27142060
NSUN2_HUMANNSUN2physical
27142060
1433G_HUMANYWHAGphysical
27142060
RT34_HUMANMRPS34physical
27142060
QSER1_HUMANQSER1physical
27142060
H33_HUMANH3F3Aphysical
27142060
H31_HUMANHIST1H3Aphysical
27142060
H31T_HUMANHIST3H3physical
27142060
1433F_HUMANYWHAHphysical
27142060
RL22L_HUMANRPL22L1physical
27142060

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BRD1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-368; LYS-418; LYS-516;LYS-519; LYS-523 AND LYS-903, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128 AND SER-1055, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128; THR-1051 ANDSER-1055, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1052 AND SER-1055, ANDMASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND MASSSPECTROMETRY.

TOP